Search All Tech Briefings

Search technology briefings produced by NIHR Innovation Observatory. These are short reports on new or repurposed medicines that we have already sent to our stakeholders. Only those technologies (medicines) that are within the scope of our stakeholders will have a technology briefing available.  Search our technology briefings by intervention (drug or device), specific indication (disease or condition), or general therapeutic area.

| 185 Results

Intervention Indication Therapeutic Area Year Actions
Basal Insulin-Fc for treating type 1 diabetes Basal Insulin-Fc Type 1 diabetes Endocrine Nutritional and Metabolic Disorders 2023 View  |  Download
AZD3152 for preventing COVID-19 AZD3152 COVID-19 Infectious Disease 2023 View  |  Download
Avacincaptad pegol for the treatment of geographic atrophy secondary to age-related macular degeneration Avacincaptad pegol Age-related macular degeneration (AMD) , Geographic atrophy Ophthalmology 2023 View  |  Download
Atezolizumab with paclitaxel and carboplatin for previously untreated advanced endometrial cancer Atezolizumab (Tecentriq; MPDL3280A) , Carboplatin (Paraplatin) , Paclitaxel (Taxol; paclitaxel albumin) Endometrial cancer Female Reproductive Cancer 2023 View  |  Download
Aprocitentan for treating resistant hypertension Aprocitentan (ACT-132577; AC-080; ACT 13257; Actelion) Resistant hypertension Cardiovascular System 2023 View  |  Download
Apremilast for treating moderate to severe plaque psoriasis in children and young people Apremilast (Otezla; CC-10004) Plaque psoriasis Dermatology 2023 View  |  Download
Apalutamide for treating high-risk, localised or locally advanced prostate cancer Apalutamide (Erleada; ARN-509) Prostate cancer Male Reproductive Cancer 2023 View  |  Download
Amivantamab with lazertinib for previously untreated locally advanced or metastatic non-small-cell lung cancer Amivantamab (JNJ-6372; JNJ-61186372) , Lazertinib Non-small-cell lung cancer (NSCLC) Lung and Respiratory Cancer 2023 View  |  Download
Alpelisib for treating PIK3CA-related overgrowth spectrum Alpelisib (BYL719; Piqray) PIK3CA-related overgrowth spectrum (PROS) Genetic Disorders 2023 View  |  Download
Alectinib adjuvant therapy for ALK-positive non-small cell lung cancer Alectinib (Alecensa) Non-small-cell lung cancer (NSCLC) Lung and Respiratory Cancer 2023 View  |  Download
Medicine Industry's Gateway to NICE
Support for Industry
Outputs & Publications